Palantir Technologies (PLTR) reported better-than-expected first quarter results and raised its full-year guidance. The enterprise technology firm now expects f ...

Benzinga examined the prospects for many investors' favorite stocks over the last week — here's a look at some of our top ...

Hims & Hers (NYSE: HIMS) stock has been on fire in 2025, and the company just got more great news after upsizing a $450 million convertible debt offering to up to $1 billion. The ...

Volatility in the economy is causing digital health companies to rethink their strategies for the remainder of 2025.

Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Novo Nordisk (NVO) have what it takes? Let's find out.

Hims & Hers stock has surged due to impressive quarterly results, rapid weight-loss product expansion, and a strategic Novo ...

Shares of Hims & Hers have been on a wild ride recently. After a strong earnings report on Monday, the stock surged, only to sharply decline before rebounding again later on Tuesday morning. What’s ...

The Toronto Stock Exchange ’s S&P/TSX composite index finished up 20.5 points or 0.1%, having sunk to begin the trading week, ...

Hims & Hers' first-quarter 2025 performance reflects continued strength in its online revenue channel on the back of solid ...

Wall Street’s mood remained bound to the repercussions of Donald Trump’s trade war, with stocks moving away from session lows ...

Andrew Dudum; Chairman of the Board, Chief Executive Officer; Hims & Hers Health Inc Oluyemi Okupe; Chief Financial Officer; Hims & Hers Health Inc Good afternoon, ladies and gentlemen. Thank you for ...

Investors are watching closely central bank actions after chatter that the authorities were tolerating a stronger currency to win concessions from the U.S.